26 results
424B5
RPHM
Reneo Pharmaceuticals Inc
13 Nov 23
Prospectus supplement for primary offering
4:58pm
environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for our management to predict all risk factors … environment for our products and product candidates. As of the date of this prospectus supplement, we cannot specify with certainty all of the particular uses
8-K
EX-10.1
36dnp6y 5pjnnkv7ptcr
5 May 23
Reneo Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:33pm
8-K
EX-1.1
nodxs57
5 May 23
Reneo Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:33pm
424B5
ms0db0mh
4 May 23
Prospectus supplement for primary offering
5:15pm
424B5
zvsnbqee5so50onai
3 May 23
Prospectus supplement for primary offering
4:20pm
S-3
EX-1.2
gt7 lge38
2 May 22
Shelf registration
4:46pm
S-3
vwhbu
2 May 22
Shelf registration
4:46pm
10-K
50u290fz
23 Mar 22
Annual report
4:38pm